Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. | Clin Transl Immunology | 2023 | 37649975 | PubTator, text mining | PubMed |
| IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. | Sci Signal | 2023 | 37643244 | PubTator, text mining | PubMed |
| Molecular characteristics, clinical significance, and immune landscape of extracellular matrix remodeling-associated genes in colorectal cancer. | Front Oncol | 2023 | 37621680 | PubTator, text mining | PubMed |
| Co-existence of RUNX1-RUNX1T1 and BCR-ABL1 in acute myeloid leukemia: a case report. | Blood Res | 2023 | 37621071 | PubTator, text mining | PubMed |
| Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia. | Clin Epigenetics | 2023 | 37620919 | PubTator, text mining | PubMed |
| Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation. | Pathophysiology | 2023 | 37606386 | PubTator, text mining | PubMed |
| An ETV6::NTRK3 fusion transcript in a core-binding factor acute myeloid leukemia. | EJHaem | 2023 | 37601839 | PubTator, text mining | PubMed |
| An "unexpected" role for EMT transcription factors in hematological development and malignancy. | Front Immunol | 2023 | 37600794 | PubTator, text mining | PubMed |
| Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs. | Blood | 2023 | 37595278 | PubTator, text mining | PubMed |
| Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications. | BMJ Case Rep | 2023 | 37591621 | PubTator, text mining | PubMed |
| Prevalence of Gene Rearrangement by Multiplex PCR in De Novo Acute Myeloid Leukemia in Adult Iraqi Patients. | J Blood Med | 2023 | 37588276 | PubTator, text mining | PubMed |
| Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease. | J Hematol Oncol | 2023 | 37587502 | PubTator, text mining | PubMed |
| Linked-read based analysis of the medulloblastoma genome. | Front Oncol | 2023 | 37576901 | PubTator, text mining | PubMed |
| LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1. | Cell Death Dis | 2023 | 37573405 | PubTator, text mining | PubMed |
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia. | Ann Hematol | 2023 | 37572135 | PubTator, text mining | PubMed |
| Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children. | Int J Mol Sci | 2023 | 37569694 | PubTator, text mining | PubMed |
| Cryotherapy Attenuates Inflammation via the lncRNA SNHG1/miR-9-5p/NFKB1 Regulatory Axis in Periodontal Ligament Cells. | Int J Mol Sci | 2023 | 37569472 | PubTator, text mining | PubMed |
| The Therapeutic Potential of a Strategy to Prevent Acute Myeloid Leukemia Stem Cell Reprogramming in Older Patients. | Int J Mol Sci | 2023 | 37569414 | PubTator, text mining | PubMed |
| YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells. | Cancers (Basel) | 2023 | 37568827 | PubTator, text mining | PubMed |
| The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms. | Cells | 2023 | 37566041 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=13